Corlieve Therapeutics Investors

26 investors on Angel Roster list Corlieve Therapeutics in their portfolio. Most are private equity firms and venture capital firms, the most common stage is Seed and the largest groups are based in France, Switzerland and Germany.

Investors are matched on the company name in their portfolio, so companies that share the name Corlieve Therapeutics can appear together.

Investors listed
26
With verified email
31%
Most common stage
Seed
Top location
France

Updated October 13, 2026 · How we compile this data

Top 26 Corlieve Therapeutics investors

The most complete profiles first. Showing 26 of 26.

  • Philippe PeltierVerified

    Venture Capital, Investor · France

    SeedHealth CareHospitalsCRMEducation

    Portfolio: Implanet, AM Pharma, FeetMe, Advanced Perfusion Diagnostics and 36 more

    Verified email available

  • Thierry LaugelVerified

    Venture Capital, Private Equity Firm, Investor · France

    SeedHealth CareHospitalsCRMEducation

    Portfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more

    Verified email available

  • Vanessa MalierVerified

    Venture Capital, Investor · France

    SeedHealth CareHospitalsCRMEducation

    Portfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more

    Verified email available

  • Bao DinhVerified

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Contact details available

  • Christophe SimonVerified

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Contact details available

  • Eric GallerneVerified

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Contact details available

  • Luc MaruendaVerified

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Verified email available

  • Matthieu BaretVerified

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Verified email available

  • Nicolas DebockVerified

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Verified email available

  • Nicolas NedelecVerified

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Verified email available

  • Robin RivatonVerified

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Verified email available

  • Amine MAROUF

    Venture Capital, Private Equity Firm, Investor · France

    SeedHealth CareHospitalsCRMEducation

    Portfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more

    Contact details available

  • Annette Fainbloom

    Venture Capital, Private Equity Firm, Investor · France

    Series BHealth CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Contact details available

  • Hadrien Bouchez

    Venture Capital, Private Equity Firm, Investor · Netherlands

    SeedHealth CareHospitalsCRMEducation

    Portfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more

    Contact details available

  • Matthieu B.

    Venture Capital, Private Equity Firm, Investor · France

    SeedPre-SeedHealth CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Contact details available

  • Nicolas de Loiray

    Venture Capital, Private Equity Firm, Investor · France

    Series BHealth CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Contact details available

  • Sylvain Cascarino

    Venture Capital, Private Equity Firm, Investor · France

    SeedHealth CareHospitalsCRMEducation

    Portfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more

    Contact details available

  • Dominik Escher

    Venture Capital, Investor · Switzerland

    SeedHealth CareLife ScienceBiotechnologyMedical

    Portfolio: AM Pharma, Vico Therapeutics, NovaGo Therapeutics, Corlieve Therapeutics and 5 more

    Contact details available

  • Daniel Emersleben

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Contact details available

  • Florian Zimmermann

    Private Equity Firm · Germany

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Contact details available

  • Jean Plamondon

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Contact details available

  • Nicolas Chaudron

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Contact details available

  • Peter Neubeck

    Venture Capital, Private Equity Firm · Germany

    Health CareHospitalsCRMEducation

    Portfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more

    Contact details available

  • Thierry Legeais

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Contact details available

  • Anja Harmeier

    Venture Capital · Switzerland

    Health CareLife ScienceBiotechnologyMedical

    Portfolio: AM Pharma, Vico Therapeutics, NovaGo Therapeutics, Corlieve Therapeutics and 4 more

    Contact details available

  • Klaus Breiner

    Venture Capital, Private Equity Firm · Switzerland

    Health CareLife ScienceBiotechnologyMedical

    Portfolio: AM Pharma, Vico Therapeutics, NovaGo Therapeutics, Corlieve Therapeutics and 4 more

    Contact details available

Frequently asked questions

How many Corlieve Therapeutics investors are on Angel Roster?

Angel Roster lists 26 Corlieve Therapeutics investors. 8 of them (31%) include a verified email address.

What types of investors are they?

The most common investor types are Private Equity Firms (22) and Venture Capital Firms (13). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Corlieve Therapeutics investors invest in?

Among those that list a stage, the most common are Seed (8), Series B (2) and Pre-Seed (1).

Where are Corlieve Therapeutics investors based?

Most are based in France (20), Switzerland (3) and Germany (2).

Which companies have Corlieve Therapeutics investors backed?

The most-backed portfolio companies among them are Vico Therapeutics (26), AM Pharma (26), Ermium Therapeutics (23), Pharvaris (23) and IO Biotech (23).

How do I contact Corlieve Therapeutics investors?

Create a free Angel Roster account to search and filter all 26, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.